PubMed Health⌕ Search

Biomedical subjects

Charles Young

Publications and source records attributed to Charles Young.

6 recordsLinked to original sources

A quantitative electrochemiluminescence assay for Clostridium perfringens alpha toxin.

Described is a rapid direct sandwich format electrochemiluminescence assay for identifying and assaying Clostridium perfringens alpha toxin. Biotinylated antibodies to C. perfringens alpha toxin bound to streptavidin paramagnetic beads specifically immunoadsorbed soluble sample alpha toxin which subsequently selectively immunoadsorbed ruthenium (Ru)-labeled detection antibodies. The ruthenium chelate of detection antibodies chemically reacted in the presence of tripropylamine and upon electronic stimulation emitted photons (electrochemiluminescence) that were detected by the photodiode of the detector. Elevated toxin concentrations increased toxin immunoadsorption and the specific immunoadsorption of Ru-labeled antibodies to alpha toxin, which resulted in increased dose-dependent electrochemiluminescent signals. The standardized assay was rapid (single 2.5-h coincubation of all reagents), required no wash steps, and had a sensitivity of about 1 ng/ml of toxin. The assay had excellent accuracy and precision and was validated in buffer, serum, and urine with no apparent matrix effects.

Antibodies↗

Evidence of nuclear reactions in the Pd lattice.

An operating Pd//D2O, Li+, Cl(-)//Pt cell, placed in an external electrostatic field, yielded unexpected results, viz. (i) Morphological changes in the form of discrete sites exhibiting molten-like features, i.e. features that require substantial energy expenditure. (ii) Presence of elements (Al, Mg, Ca, Si, Zn, ...) that could not be extracted from cell components and deposited on discrete sites. The cell design and the experimental protocol assuring reproducibility is described in detail.

Journal Article↗

Molecular cloning and characterization of human homeobox gene Nkx3.1 promoter.

Nkx3.1 is a prostate-specific homeobox gene related strongly to prostate development and prostate cancer. To study its regulation of transcription, 1.06 kb 5' flanking region of Nkx3.1 gene and its 5' deletion mutants (861, 617, 417 and 238 bp) were obtained by PCR and cloned into pGL(3)-basic, a promoter-less luciferase reporter vector, to examine their promoter activities driving the reporter gene transcription. pRL-TK, a Renilla luciferase reporter vector was used as internal control, and pGL(3)-control and pGL(3)-basic were used as positive and negative control respectively. The promoter activities were determined by dualluciferase reporter assay 48 h after pGL(3) constructs were cotransfected with pRL-TK into prostate cancer cell LNCaP. The results showed that dual-luciferase reporter assay (M(1)/M(2)) of pGL(3)-1.06 kb cotransfection with pRL-TK was 2.7, which was about 1.5-fold higher than that of pGL(3)-control cotransfection with pRL-TK and 50-fold higher than that of pGL(3)-basic cotransfection with pRL-TK. The results also showed that the relative activities (M(1)/M(2)) were 0.71, 0.84, 0.44 and 2.07 respectively for pGL(3)-861 bp, pGL(3)-617 bp, pGL(3)-417 bp, pGL(3)-238 bp, the last one still had 80% promoter activity compared with pGL(3)-1.06 kb, which showed that deletion from 1.06 kb to 238 bp had small effects on promoter activity. The conclusion was that the 238 bp fragment containing a TATA box and two CAAT boxes had strong promoter activity. However, the deletion from 1.06 kb to 861 bp reduced activity 3.8-fold while the deletion from 417 bp to 238 bp enhanced activity 4.7-fold, which indicated that these deleted sequences might contain some important positive or negative regulatory elements. It will be important to identify the elements within the Nkx3.1 promoter that contribute to regulation of the gene transcription in the future studies.

Amino Acid Sequence↗

Extreme medicine.

Extreme Adj Very high or highest in degree or intensity. Very far, or furthest, in any direction, especially out from the centre. Very violent or strong. Not moderate; severe.

Humans↗